Sentinel node biopsy Market Overview
The global sentinel node biopsy market is growing pervasively mainly due to the increasing prevalence of various types of cancer including melanoma, colon cancer, breast cancer, esophageal cancer, head and neck cancer among others. Moreover, the spreading awareness towards the advantages of sentinel node biopsy escalates its market on the global platform.
Additional factors propelling the growth of the sentinel node biopsy market share include the changing lifestyle led by the growing urbanization & industrialization. Improving economic conditions worldwide are defining the growth of the sentinel node biopsy market, enabling access to the quality of life & to the improved healthcare. Furthermore, factors such as increasing number of biopsy procedures and rising demand for new techniques for the diagnosis of cancerous growth provide significant impetus to the market growth.
Key players leading the global sentinel node biopsy market include Devicor Medical Products, Inc. (Germany), C. R. Bard, Inc. (U.S.), Hilfe Engineering Corporation (India), Intramedical Imaging LLC (U.S.), KUB Technologies, Inc. (U.S.), Surgic Eye (Germany), and Navidea Biopharmaceuticals, Inc. (U.S.) among others.
Acknowledging the exponential traction, the market is witnessing currently, Market Research Future (MRFR) in its recently published a study report asserts that the global sentinel node biopsy market will witness significant accruals by 2023 registering 5.1 % CAGR during the review period (2017 to 2023).
Global Sentinel node biopsy Market Segment
The MRFR analysis is segmented into four key dynamics for enhanced understanding.
- By Product : Breast Localization Wire, Tissue Marker, Gamma Probe, and Drainage Catheters among others.
- By Indication: Breast Cancer, Melanoma, Colon Cancer, and Esophageal Cancer among others.
- By End-user : Hospitals & Clinics, and Diagnostic Centers among others.
- By Regions : North America, Asia Pacific, Europe, and the Rest-of-the-World.
Sentinel node biopsy Market Regional Analysis
The North American region, heading with the increasing number of market players offering biopsy devices and instruments, accounts for the leading market for sentinel node biopsy, globally. Factors such as the extensive and early uptake of medical technology for advancing medical devices and the increasing governmental support for R&D activities alongside the high health care expenditures substantiate the market growth in the region.
Furthermore, the increasing number of women suffering from breast disorders and rising prevalence of breast cancer along with the availability of quality care drives the growth of the regional market. With the constant developments by companies operating in cancer diagnostics, the market is expected to create the major revenue pocket during the review period.
The sentinel node biopsies market in the European region led by the increasing emphasis on the development of advent diagnostic devices, accounts for the next largest market, globally. Moreover, factors propelling the growth of the regional market include rising government support with the increased funding for R&D activities in the field of oncology and the rising numbers of specialty services offered by various healthcare providers.
Germany leads the European sentinel node biopsies market owing to an increasing demand for cancer diagnosis. Whereas France and the U.K heading with the availability of tertiary care facilities in these countries and rising healthcare expenditures, secure second and third position, respectively.
Global Sentinel Node Biopsy Market- Competitive Analysis
The global sentinel node biopsy market appears intensely competitive and fragmented with a large number of players churning the competition. Players employ a continuous improvement strategy to analyze and update tests, implement improvements and launch new solutions to meet the changing demands of both patients and healthcare professionals.
These key players invest heavily in developing the pipeline of innovative tests to address unmet patient needs. They strive to develop non-invasive, comprehensive and proven effective, tests that can help to match advanced-cancer patients with the approved targeted therapies as well as drugs in clinical trials.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: info@marketresearchfuture.com
0
